Certest Presents Viasure Complete Solution for Molecular Diagnostic Laboratories

CerTest will also highlight its newly-launched Viasure Monkeypox Virus Real Time PCR Detection Kit at AACC 2022.

The VIASURE Complete Solution being presented by CerTest at AACC 2022 includes RNA/DNA pathogen extraction kits, nucleic acid extraction and PCR set-up system, RT PCR detection kits, RT PCR system and software, and RNA viral particles. VIASURE Complete Solution includes the VIASURE V-FLEX system, a new fully automated solution in molecular biology for nucleic acid extraction, purification and PCR set-up from biological matrix and samples. The instrument has been designed with flexible configuration, in order to meet different user needs. Also a part of VIASURE Complete Solution is the VIASURE V-Lab96 Advanced RT PCR System with 96-well block for high sample throughput in diagnostic lab applications. VIASURE V-Lab96 allows users to analyze 96 samples simultaneously for qualitative and quantitative PCR. Also included is the VIASURE V-Smart software for the analysis and interpretation of VIASURE RT PCR assays. The VIASURE V-Smart software facilitates the conversion of the PCR raw data into test results with minimal manual intervention.

VIASURE DNA/RNA Pathogen Extraction Kit allows extraction from various biological samples such as swabs, saliva, sputum, bronchoalveolar lavages, fecal and urine samples. The kit is based on magnetic particles, which allows its automation for high throughput analysis, reducing hands-on-time and improving reproducibility. The extraction kit has been optimized for two types of magnetic separation methods: VIASURE V-Flex and KingFisher Flex (other platforms ongoing). Additionally, VIASURE Real Time PCR Detection Kits allow for simultaneous detection of multiple targets in a broad range of multiplexing diagnostic panels, including in the area of antimicrobial resistance.

At AACC 2022, CerTest is also showcasing its new VIASURE Monkeypox Virus Real Time PCR Detection Kit for the qualitative identification of monkeypox virus DNA in samples from patients suspected of infection. The new diagnostic assay is offered in a lyophilized format, like the entire VIASURE product range, which allows the product to be shipped and stored at room temperature without the need for special transport conditions.
 

Related Links:
CerTest Biotec